Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response Inhibition”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00576329
What this trial is testing

Topical 0.4% Ketorolac and Vitreoretinal Surgery

Who this might be right for
Surgery
Emory University 76
Very early researchStudy completedNCT03105375
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study

Who this might be right for
Healthy Volunteers
Cinclus Pharma Holding AB 39
Not applicableStudy completedNCT01677819
What this trial is testing

Inhibition Control of Children and Adolescents With ADHD

Who this might be right for
Attention Deficit Hyperactivity Disorder
National Taiwan University Hospital 60
Post-approval studies (Phase 4)Study completedNCT03168295
What this trial is testing

PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria

Who this might be right for
Diabetes Mellitus, Type 2
The University of Texas Health Science Center at San Antonio 34
Large-scale testing (Phase 3)Study completedNCT00604357
What this trial is testing

CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment

Who this might be right for
End Stage Liver DiseaseImpaired Renal Function
University of Regensburg 27
Large-scale testing (Phase 3)UnknownNCT01654367
What this trial is testing

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University 300
Testing effectiveness (Phase 2)Ended earlyNCT05435053
What this trial is testing

Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Ismail Gögenur 9
Large-scale testing (Phase 3)Study completedNCT01515345
What this trial is testing

Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry

Who this might be right for
Platelet InhibitionCoronary Stent Implantation
Kaiser Franz Josef Hospital 1,008
Post-approval studies (Phase 4)Study completedNCT00654628
What this trial is testing

Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)

Who this might be right for
Hypercholesterolemia
Organon and Co 173
Not applicableStudy completedNCT01718730
What this trial is testing

Cortical Excitability and Inhibition in MDD

Who this might be right for
Major Depressive Disorder, Recurrent, MildDepressive Disorder, Major
Mayo Clinic 23
Testing effectiveness (Phase 2)Looking for participantsNCT07213934
What this trial is testing

Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerRecurrent Head and Neck Squamous Cell Carcinoma
University of Cincinnati 40
Early research (Phase 1)Looking for participantsNCT06299839
What this trial is testing

PAS-004 in Patients With Advanced Solid Tumors

Who this might be right for
RAS MutationNF1 MutationRAF Mutation+1 more
Pasithea Therapeutics Corp. 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT05947500
What this trial is testing

Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial

Who this might be right for
Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8Locally Advanced Merkel Cell Carcinoma+3 more
National Cancer Institute (NCI)
Not applicableUnknownNCT01172795
What this trial is testing

Diffuse Noxious Inhibitory Controls (DNIC): Nociceptive Modulation and Interaction With Neurocognitive Performance in Chronic Pain

Who this might be right for
FibromyalgiaWhiplashChronic Pain
Vrije Universiteit Brussel 100
Testing effectiveness (Phase 2)Study completedNCT01752400
What this trial is testing

AUY922 for Advanced ALK-positive NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Massachusetts General Hospital 6
Post-approval studies (Phase 4)UnknownNCT04299971
What this trial is testing

Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients

Who this might be right for
Takayasu ArteritisMethotrexateInhibition+1 more
Shanghai Zhongshan Hospital 130
Post-approval studies (Phase 4)UnknownNCT02742233
What this trial is testing

Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers

Who this might be right for
Diabetic Foot Ulcer
Long Min,MD 60
Post-approval studies (Phase 4)Study completedNCT00681226
What this trial is testing

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Bayside Health 200
Post-approval studies (Phase 4)Looking for participantsNCT07581808
What this trial is testing

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease (ASCVD)
University Medical Centre Ljubljana 60
Not applicableLooking for participantsNCT05447338
What this trial is testing

Manual Therapy in Patients With Neck Pain

Who this might be right for
Neck Pain
Universidad Nacional de Córdoba 114
Next Page
50